Home
>
US Stocks
>
Zynerba Pharmaceuticals Inc
Zynerba Pharmaceuticals Inc
ZYNE

Zynerba Pharmaceuticals Inc (ZYNE)

$3.884.9%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
3.98
Today Low/High
3.82 / 3.98
52 Week Low/High
$3.15 / $9
Market Cap
$162.12M

Company Details

Zynerba Pharmaceuticals is the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. Zynerba Pharmaceuticals is committed to improving the lives of patients and their families living with severe, chronic health conditions including Fragile X syndrome, autism spectrum disorder, 22q11.2 deletion syndrome, and a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies.
Organisation
Zynerba Pharmaceuticals Inc
Headquaters
Devon, Pennsylvania, US
Employees
26
Industry
Health Technology
CEO
Armando Anido

Discover more

Frequently Asked Questions

What is Zynerba Pharmaceuticals Inc (ZYNE) share price today?

Can Indians buy Zynerba Pharmaceuticals Inc (ZYNE) shares?

How can I buy Zynerba Pharmaceuticals Inc (ZYNE) shares from India?

Can Fractional shares of Zynerba Pharmaceuticals Inc (ZYNE) be purchased?

What are the documents required to start investing in Zynerba Pharmaceuticals Inc (ZYNE) stocks?

We are a SEBI registered investement advisor